Organon
Carol Ferguson is a seasoned executive with extensive experience in business development and investor relations within the pharmaceutical industry. Currently serving as Vice President of Business Development at Organon since June 2021, Carol previously held various strategic roles at Merck from July 2003 to May 2021, including Executive Director positions in Business Development and Investor Relations. In these roles, Carol led commercial business development initiatives, directed investor communications, and developed portfolio management frameworks, contributing significantly to corporate strategy and financial performance. Carol holds an MBA in Finance from the University of Virginia Darden School of Business and a Bachelor of Science in Accounting from Virginia Commonwealth University.
This person is not in any teams
Organon
20 followers
At Organon, they envision a better and healthier every day for every woman. The diversity of their business provides a sustainable engine of growth so they can identify and invest in solutions for women. Their mission is to deliver impactful medicines and solutions for a healthier every day.